Makady A - Search Results

Year	Number of Results
2015	1
2017	6
2018	5
2019	7
2020	2
2021	1
2022	2
2023	2
2024	3
2025	0

1

What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews.

Makady A, de Boer A, Hillege H, Klungel O, Goettsch W; (on behalf of GetReal Work Package 1). Makady A, et al. Value Health. 2017 Jul-Aug;20(7):858-865. doi: 10.1016/j.jval.2017.03.008. Epub 2017 May 11. Value Health. 2017. PMID: 28712614 Free article. Review.

2

Get real in individual participant data (IPD) meta-analysis: a review of the methodology.

Debray TP, Moons KG, van Valkenhoef G, Efthimiou O, Hummel N, Groenwold RH, Reitsma JB; GetReal Methods Review Group. Debray TP, et al. Res Synth Methods. 2015 Dec;6(4):293-309. doi: 10.1002/jrsm.1160. Epub 2015 Aug 19. Res Synth Methods. 2015. PMID: 26287812 Free PMC article. Review.

3

Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines.

Moseley J, Vamvakas S, Berntgen M, Cave A, Kurz X, Arlett P, Acha V, Bennett S, Cohet C, Corriol-Rohou S, Du Four E, Lamoril C, Langeneckert A, Koban M, Pasté M, Sandler S, Van Baelen K, Cangini A, García S, Obach M, Gimenez Garcia E, Varela Lema L, Jauhonen HM, Rannanheimo P, Morrison D, Van De Casteele M, Strömgren A, Viberg A, Makady A, Guilhaume C. Moseley J, et al. Among authors: makady a. Br J Clin Pharmacol. 2020 Jun;86(6):1034-1051. doi: 10.1111/bcp.14279. Epub 2020 Apr 24. Br J Clin Pharmacol. 2020. PMID: 32162368 Free PMC article. Review.

4

Cancer treatments touch a wide range of values that count for patients and other stakeholders: What are the implications for decision-making?

Vrinzen CEJ, Bloemendal HJ, Stuart E, Makady A, van Agthoven M, Koster M, Merkx MAW, Hermens RPMG, Jeurissen PPT. Vrinzen CEJ, et al. Among authors: makady a. Cancer Med. 2023 Mar;12(5):6105-6116. doi: 10.1002/cam4.5336. Epub 2022 Nov 14. Cancer Med. 2023. PMID: 36373590 Free PMC article.

5

Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies.

Adamson B, Makady A, Sarri G, Mohamed O, Babar Z, Dawoud DM. Adamson B, et al. Among authors: makady a. Front Pharmacol. 2024 Apr 18;15:1396034. doi: 10.3389/fphar.2024.1396034. eCollection 2024. Front Pharmacol. 2024. PMID: 38698818 Free PMC article. No abstract available.

6

Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies.

Makady A, Ham RT, de Boer A, Hillege H, Klungel O, Goettsch W; GetReal Workpackage 1. Makady A, et al. Value Health. 2017 Apr;20(4):520-532. doi: 10.1016/j.jval.2016.12.003. Epub 2017 Jan 27. Value Health. 2017. PMID: 28407993 Free article. Review.

7

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease.

Bouvy JC, Jonsson P, O'Rourke D, Chadha AS, Hedberg N, Makady A, Xoxi E, Wied CG, Schiel A, Long R, Gallacher J. Bouvy JC, et al. Among authors: makady a. CNS Drugs. 2018 Dec;32(12):1085-1090. doi: 10.1007/s40263-018-0581-x. CNS Drugs. 2018. PMID: 30467744 Free PMC article.

8

Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants.

Schulthess D, Gassull D, Makady A, Ludlow A, Rothman B, Have PT, Wu Y, Ekstrom L, Minnema M, Jagasia M. Schulthess D, et al. Among authors: makady a. BMJ Evid Based Med. 2021 Jun;26(3):98-102. doi: 10.1136/bmjebm-2019-111226. Epub 2019 Jul 17. BMJ Evid Based Med. 2021. PMID: 31315904 Free PMC article.

9

Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study.

Makady A, Kalf RRJ, Ryll B, Spurrier G, de Boer A, Hillege H, Klungel OH, Goettsch W; GetReal Workpackage 1. Makady A, et al. Health Qual Life Outcomes. 2018 Nov 29;16(1):222. doi: 10.1186/s12955-018-1047-z. Health Qual Life Outcomes. 2018. PMID: 30497502 Free PMC article.

10

Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease.

Dekker MJHJ, Bouvy JC, O'Rourke D, Thompson R, Makady A, Jonsson P, Gispen-de Wied CC. Dekker MJHJ, et al. Among authors: makady a. Front Med (Lausanne). 2019 May 7;6:73. doi: 10.3389/fmed.2019.00073. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31134200 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year